$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Abstract AI-Helper 아이콘AI-Helper

This study was designed to elucidate whether combination with Korean red ginseng and Morus alba L. (MPM), traditional treatment for diabetes, ameliorates on high fructose-induced steatohepatitis and vascular inflammation. Animals were divided into four groups; Control receiving tap water, fructose-f...

주제어

참고문헌 (38)

  1. Georg, P., Ludvik, B. Lipids and diabetes. J. Clin. Basic. Cardiol. 3: 159-162, 2000. 

  2. International Diabetes Federation. Diabetes Atlas, 2nd ed, 2003 Available at: www.eatlas.idf.org (accessed on July 12, 2008). 

  3. Yoon, K.H., Lee, J.H., Kim, J.W., Cho, J.H., Choi, Y.H., Ko, S.H., Zimmet, P., Son, H.Y. Epidemic obesity and type 2 diabetes in Asia. Lancet. 11: 1681-1688, 2006. 

  4. Tay, S.S., Mc Cormack, A., Rose, M.L. Effect of cognate human CD4+ Tcell and endothelial cell interactions upon chemokine production. Transplantatio.n 78(7):987-994, 2004. 

  5. Uze, G., Pachman, L.M. Cytokines in juvenile dermatomyositis pathophysiology: potential and challenge. Curr. Opin. Rheumatol. 15(6):691-697, 2003. 

  6. Frostegard, J., Wu, R., Haegerstrand, A., patarroyo, M., Lefver,, A.K. Mononuclear leukocytes exposed to oxidized low density lipoprotein secrete a factor that stimulates endothelial cells to express adhesion molecules. Atherosclerosis. 103: 213-219, 1993. 

  7. Mes, Bouhle., M.A., Staels, B., Chinetti-Gbaguid, G. Peroxisome proliferator-activated receptors-from active regulators of macrophage biology to pharmacological targets in the treatment of cardiovascular disease. J. Intern. Med. 263(1):28-42, 2008. 

  8. Li, J.J., Zhu, C.G., Yu, B., Liu, Y.X., Yu, M.Y. The role of inflammation in coronary artery calcification. Agening. Res. Rev. 6(4):263-270, 2007. 

  9. Matteoni, C.A., Younossi, Z.M., Gramlich, T., Boparai, N., Liu, Y.C., Mc, Cullough, A.J. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 116: 1413-1419, 1999. 

  10. Bugianesi, E., Leone, N., Vanni, E., Marchesini, G., Brunello, F., Rizzetto, M. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology. 123: 134-140, 2002. 

  11. Marrero, J.A., Fontana, R.J., Su, G.L., Conjeevaram, H.S., Emick, D.M., Lok, A.S. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology. 36: 1349-1354, 2002. 

  12. Jun, D.W. Non-alcoholic fatty liver disease. Korean J. Hepatol. 17: S332-S336, 2011. 

  13. Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., Rizzetto, M. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 37: 917-923, 2003. 

  14. Hong, M.H., Lim, H.K., Park, J.E., Jun, N.J., Lee, Y.J., Cho, M.J., Kim, S.M. The Antihypertensive and Vasodilating Effects of Adventitious Root Extracts of Wild Ginseng. J. Korean. Soc. Appl. Biol. Chem. 51: 102-107, 2008. 

  15. Mizuno, M., Yamada, J., Terai, H., Kozukue, N., Lee, Y.S., Tsuchide, H. Differences in immunomodulating effects between wild and cultured Panax ginseng. Biochem. Biophys. Res. Commun. 200: 1672-1678, 1994. 

  16. Kwon, K.R., Park, W.P., Kang, W.M., Jeon, E.Y., Jang, J.H. Identification and analysis of differentially expressed genes in mountain cultivated ginseng and mountain wild ginseng. J. Acupunct. Meridian. Stud. 4: 123-128, 2011. 

  17. Liu, C.X., Xiao, P.G. Recent advances on ginseng research in China. J. Ethnopharmacol. 36: 27-38, 1992. 

  18. Kitts, D., Hu, C. Efficacy and safety of ginseng. Public. Health. Nutr. 3: 473-485, 2000. 

  19. Enkhmaa, B., Shiwaku, K., Katsube, T., Kitajima, K., Anuurad, E., Yamasaki, M., Yamane, Y. Mulberry (Morus alba L.) leaves and their major flavonol quercetin 3-(6-malonylglucoside) attenuate atherosclerotic lesion development in LDL receptor-deficient mice. J. Nutr. 135: 729-734, 2005. 

  20. Miyahara, C., Miyazawa, M., Satoh, S., Sakai, A., Mizusaki, S. Inhibitory effects of mulberry leaf extract on postprandial hyperglycemia in normal rats. J. Nutr. Sci. Vitaminol. 50: 161-164, 2004. 

  21. Lee, Y.J., Choi, D.H., Kim, E.J., Kim, H.Y., Kwon, T.O., Kang, D.G., Lee, H.S. Hypotensive, hypolipidemic, and vascular protective effects of Morus alba L. in rats fed an atherogenic diet. Am. J. Chin. Med. 39: 39-52, 2011. 

  22. Park, S.H., Jeon, W.K., Kim, S.H., Kim, H.J., Park, D.I., Cho, Y.K., Sung, I.K., Sohn, C.I., Keum, D.K., Kim, B.I. Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J. Gastroenterol. Hepatol. 21: 138-143, 2006. 

  23. Elliott, S.S., Keim, N.L., Stern, J.S., Teff, K., Havel, P.J. Fructose, weight gain, and the insulin resistance syndrome. Am. J. Clin. Nutr. 76: 911-922, 2002. 

  24. Hwang, I.S., Ho, H., Hoffman, B.B., Reaven, G.M. Fructose-induced insulin resistance and hypertension in rats. Hypertension. 10: 512-516, 1987. 

  25. Sanchez-Lozada, L.G., Tapia, E., Jimenez, A., Bautista, P., Cristobal, M., Nepomuceno, T., Soto, V., Avila-Casado, C., Nakagawa, T., Johnson, R.J, Herrera-Acosta, J., Franco, M. Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am. J. Physiol. Renal. Physiol. 292: 423-429, 2007. 

  26. Feingold, K.R., Grunfeld, C. Role of cytokines in inducing hyperlipidemia. Diabetes. 41: 97-101, 1992. 

  27. Stenvinkel, P., Heimburger, O., Jogestrand, T. Elevated interleukin-6 predicts progressive carotid artery atherosclerosis in dialysis patients: Association with Chlamydia pneumoniae seropositivity. Am. J. Kidney. Dis. 39: 274-282, 2002. 

  28. Duprez, D.A., Somasundaram, P.E., Sigurdsson, G., Hoke, L., Florea, N., Cohn, J.N. Relationship between Creactive protein and arterial stiffness in an asymptomatic population. J. Hum. Hypertens. 19: 515-519, 2005. 

  29. Hommels, M.J, van der Ven A.J.A.M., Kroon, A.A., Kessels, A.G.H., Van Dieijen-Visser, M.P., Van Engelshoven, J.A.M., Bruggeman, C.A., De Leeuw, P.W. C-reactive protein, atherosclerosis and kidney function in hypertensive patients. J. Hum. Hypertens. 19: 521-526, 2005. 

  30. Quagliaro, L., Piconi, L., Assaloni, R., Da Ros, R., Maier, A., Zuodar, G., Schreyer, S.A., Vick, C., Lystig, T.C., Mystkowski, P., LeBoeuf, R.C. LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice. Am. J. Physiol. Endocrinol. Metab. 282: 207-214, 2002. 

  31. Diehl, A.M. Nonalcoholic steatohepatitis. Semin. liver. dis. 19: 220-229, 1999. 

  32. Akyuz, F., Demir, K., Ozdil, S., Aksoy, N., Poturoglu, S., Ibrisim, D., Kaymakoglu, S., Besisik, F., Boztas, G., Cakaloglu, Y., Mungan, Z., Cevikbas, U., Okten, A. The effects of rosiglitazone, metformin, and diet with exercise in nonalcoholic fatty liver disease. Dig. Dis. Sci. 52:2359-2367, 2007. 

  33. Neuschwander-Tetri, B.A., Brunt, E.M., Wehmeier, K.R., Oliver, D., Bacon, B.R. Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone. Hepatology. 38: 1008-1017, 2003. 

  34. Belfort, R., Harrison, S.A., Brown, K., Darland, C., Finch, J., Hardies, J., Balas, B., Gastaldelli, A., Tio, F., Pulcini, J., Berria, R., Ma, J.Z., Dwivedi, S., Havranek, R., Fincke, C., DeFronzo, R., Bannayan, G.A., Schenker, S., Cusi, K. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N. Engl. J. Med. 355: 2297-2307, 2006. 

  35. Promrat, K., Lutchman, G., Uwaifo, G.I., Freedman, R.J., Soza, A., Heller, T., Doo, E., Ghany, M., Premkumar, A., Park, Y., Liang, T.J., Yanovski, J.A., Kleiner, D.E., Hoofnagle, J.H. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. Hepatology. 39: 188-196, 2004. 

  36. Fortez, M., Ancellin, N., Andreelli, F., Saintillan, Y., Grondin, P., Kahn, A., Thorens, B., Vaulont, S., Viollet, B. Short-term overexpression of a constitutively active form of AMPK-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver. Diabetes. 54: 1331-1339, 2005. 

  37. Nielsen, S., Guo, Z., Johnson, C.M., Hensrud, D.D., Jensen, M.D. Splanchnic lipolysis in human obesity. J. Clin. Invest. 113: 1582-1588, 2004. 

  38. Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 114: 1752-1761, 2004. 

저자의 다른 논문 :

LOADING...

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로